A class action lawsuit has been initiated against Inovio Pharmaceuticals, Inc. (NASDAQ: INO) by shareholders. The complaint alleges that the company made false or misleading statements and failed to disclose important information to investors.
The case was filed in Atlanta on February 9, 2026, and claims that these actions negatively impacted shareholders by affecting the company’s stock value.
**Why this matters**
Lawsuits of this nature can influence investor confidence and potentially affect the company’s financial standing. Shareholders should monitor developments as the case proceeds to understand any implications for their investments.
Source: NewsData